The 2020 pandemic hit many companies hard, while other companies took it as a chance to grow, seemingly unaffected by the state of the world around them. NVIDIA (NASDAQ:NVDA) came out as one of those thriving businesses and achieved gains of 122% in 2020. The company’s graphics processing units (GPUs) were present and needed for trends that accelerated exponentially due to the pandemic, boost...
Published by: Tom Smith
Everyone remembers how much money we made with GameStop, AMC, Dogecoin and many others. Of course, the majority of my readers are on RobinHood but literally everyone who bought these stocks made a fortune.
Some of you even managed to turn $1,000 into over $1 million by rolling your profits from one of my recommendations onto the next.
Cardiol Therapeutics Inc (Ticker: CRDL) is trading in the single-digits and it could be about to run to over $80 by Christmas.
CRDL is one of the most exciting biotech companies I’ve ever come across and they are currently close to completing FDA-Approved trials.
The drugs they’ve developed are ground-breaking and could easily turn CRDL into a multi-billion-dollar business.
CRDL is a perfect candidate to bought out by one of the big pharma companies like Pfizer.
That’s because those same drugs have already proved to be extremely effective in treating heart disease: the No1 cause of death in America today.
The company’s CEO, David Elsley, founded another biotech company 30 years ago which reached a market valuation of over $1 billion.
Think about picking up shares right now while it’s still trading at affordable prices. This could be the easiest 2,000% profits our trading community makes this year.
A good price to buy CRDL now is around $4 per share.